Ligand-inducible and liver-specific target gene expression in transgenic mice

Nature Biotechnology

Volumn 15, Issue 3, 1997, Pages 239-243

  Wang, Yaolin ^a   DeMayo, Franco J ^a   Tsai, Sophia Y ^a   O’Malley, Bert W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Gene expression; Inducible gene system; Transgenic mice

Indexed keywords

ANIMAL CELL; ARTICLE; CARCINOGENESIS; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC REGULATION; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; TISSUE SPECIFICITY; TRANSACTIVATION; TRANSCRIPTION REGULATION; TRANSGENE;

ANIMALIA; MUS MUSCULUS;

EID: 0030965628     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0397-239     Document Type: Article

References (24)

1. Bienz, M. and Pelham, H.R. 1986. Heat shock regulatory elements function as an inducible enhancer in the Xenopus hsp70 gene and when linked to a heterologous promoter. Cell 45:753-760.
2. Bairn, S.B., Labow, M.A., Levine, A.J., and Shenk T. 1991. A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl β-D-thiogalactoside. Prac. Natl. Acad. Sci. USA 88:5072-5076.
3. Mayo, K.E., Warren, R., and Palmiter, R.D. 1982. The mouse metallothionein-l gene is transcriptionally regulated by cadmium following transfection into human or mouse cells. Cell 29:99-108.
4. Wang, Y, O’Malley, B.W. Jr., Tsai, S.Y., and O’Malley, B.W. 1994. A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA 91:8180-8184.
5. Gossen, M., Freundlied, S., Bender, G., Muller, G., Hillen, W. and Bujard, H. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766-1769.
6. No, D., Yao, T.-R, and Evans, R.M. 1996. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93:3346-3351.
7. Spencer, D.M., Wandless, T.J., Schreiber, S.L., and Crabtree, G.R. 1993. Controlling signal transduction with synthetic ligands. Science 262:1019-1024.
8. Yan, C, Costa, R.H., Darnell, J.E. Jr., Chen, J., and Van Dyke, TA. 1990. Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J. 9:869-878.
9. Wu, H., Wade, M., Krall, L, Grisham, J., Xiong, Y, and Van Dyke, TA. 1996. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration. Genes & Development 10:245-260.
10. Chung, J.H., Whiteley, M., and Felsenfeld, G. 1993. A 5´ element of the chicken 3-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell 74:505-514.
11. Cai, H. and Levine, M. 1995. Modulation of enhancer-promoter interactions by insulators in the Drosophila embryo. Nature 376:533-536.
12. Brand, A.H. and Perrimon, N. 1993. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118:401-415.
13. Ornitz, D.M., Moreadith, R.W., and Leder, P. 1991. Binary system for regulating transgene expression in mice: Targeting int-2 gene expression with yeast GAL4/UAS control elements. Proc. Natl. Acad. Sci. USA 88:698-702.
14. Murad, F. and Haynes, R. Jr. 1985. pp. 1366-1371, in Goodman and Gilman’s The Pharmacological Basis of Therapeutics, ed 7. MacMillan, New York.
15. Heikinheimo, O. and Kekkonen, R. 1993. Dose-response relationships of RU 486. Ann. Med. 25:71-76.
16. Shi, Y.E., Ye, Z.H., He, CH., Zhang, G.Q., Xu, J.Q., Van Look, P.F., et al., 1993. Pharmacokinetic study of RU 486 and its metabolites after oral administration of single doses to pregnant and non-pregnant women. Contraception 48:133-149.
17. Kawai, S., Nieman, L.K., Brandon, D.D., Udelsman, R., Loriaus, D.L., and Ghrousos, G.R 1987. Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid RU 486 in man. J. Pharmacol. Exp. Therapeutics 241:401-406.
18. Palmiter, P.D., Norstedt, G., Gelinas, R.E., Hammer, R.E., and Brinster, R.L. 1983. Metallothionein-human GH fusion genes stimulated growth of mice. Science 222:809-814.
19. Spitz, I.M. and Bardin, C.W. 1993 Mifepristone (RU 486)—a modulator of progestin and glucocorticoid action. N. Engl. J. Med. 329:404-412.
20. Grunberg, S.M., Weiss, M.H., Spitz, I.M., Ahmadi, J., Sadum, A., Russell, CA., et al. 1991. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J. Neursurg. 74:861-866.
21. Borgden, R.N., Goa, K.L, and Faulds, D. 1993. Mifepristone, a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 45:384-409.
22. Felsenfeld, G., Boyes, J., Chung, J., Clark, D., and Studitsky, V. 1996. Chromatin structure and gene expression. Proc. Natl. Acad. Sci. USA 93:9384-9388.
23. Zhao, Keji, Hart, C.M., and Laemmli, U.K. 1995. Visualization of chromosomal domains with boundary element-associated factor BEAF-32. Cell 81:879-889.
24. Reneker, L.W., Silversides, D.W., Patel, K., and Overbeek, P.A. 1995. TGFα can act as a chemoattractant to perioptic mesenchymal cells in developing mouse eyes. Development 121:1669-1680.